NCT00840645View on ClinicalTrials.gov

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

YM178

Oral

Trial Locations (2)

Unknown

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00840645 - A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients | Biotech Hunter | Biotech Hunter